Daniel M. Skovronsky, M.D., Ph.D., resigned from the Board of Directors of Myriad Genetics, Inc. effective June 17, 2026. The resignation was not due to any disagreement with the company regarding its operations, policies, or practices. Myriad Genetics, Inc. is a biotechnology company providing genetic testing services.
